Carregant...
NAPS-MS: Natalizumab Effects on Parameters of Sleep in Patients with Multiple Sclerosis
Background: Patients with multiple sclerosis (MS) have higher rates of fatigue, mood disturbance, and cognitive impairments than healthy populations. Disease-modifying agents may affect sleep. Although patients taking natalizumab often show improvement in fatigue during the first year of therapy, th...
Guardat en:
| Publicat a: | Int J MS Care |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
The Consortium of Multiple Sclerosis Centers
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4984789/ https://ncbi.nlm.nih.gov/pubmed/27551242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2015-033 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|